Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro

Biochimica Et Biophysica Acta. Biomembranes
Samuel C R SherrattR Preston Mason

Abstract

Oxidation of small dense low-density lipoprotein (sdLDL) and membranes is causally related to atherosclerosis. The omega-3 fatty acid (FA) eicosapentaenoic acid (EPA, 20:5, ω-3) significantly reduced oxidized LDL in patients with hypertriglyceridemia by unknown mechanisms. We compared EPA effects to related FAs of varying chain length and unsaturation on oxidation of sdLDL and model membranes, and on cholesterol crystal domains. We compared EPA to the FAs: stearic (SA, 18:0), oleic (OA, 18:1, ω-9), linoleic (LA, 18:2, ω-6), alpha-linolenic (ALA, 18:3, ω-3), eicosanoic (EA, 20:0), eicosatrienoic (ETE, 20:3, ω-3), arachidonic (AA, 20:4, ω-6), docosapentaenoic (DPA, 22:5, ω-3), and docosahexaenoic (DHA, 22:6, ω-3). Human sdLDL or model membranes of cholesterol and 1,2-Dilinoleoyl-sn-glycero-3-phosphocholine [18:2(cis)PC or DLPC] were preincubated with FAs followed by copper-induced oxidation. Malondialdehyde (MDA) or lipid hydroperoxides (LOOH) levels measured oxidation; small-angle X-ray diffraction assessed cholesterol domain formation. After 40 min, EPA reduced MDA levels 70% compared to vehicle (p < 0.001). Lesser inhibition was observed with DHA, DPA, ETE, and ALA (33%, 34%, 32%, and 16%, respectively; all p < 0.001 versus ve...Continue Reading

References

Jan 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·J L GoldsteinM S Brown
Mar 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J de GraafA F Stalenhoef
Feb 1, 1986·The Journal of Clinical Investigation·S ParthasarathyD Steinberg
Aug 1, 1965·Journal of Molecular Biology·A D BanghamJ C Watkins
Jan 1, 1984·Methods in Enzymology·K Yagi
Jan 1, 1994·Methods in Enzymology·I T Mak, W B Weglicki
Oct 1, 1994·Current Opinion in Lipidology·R M Krauss
Sep 17, 1994·Lancet·J L Witztum
Aug 14, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·G Kellner-WeibelG H Rothblat
Aug 18, 2000·Free Radical Biology & Medicine·G M Chisolm, D Steinberg
Mar 6, 2002·Circulation·Peter LibbyAttilio Maseri
Dec 20, 2002·Nature·Peter Libby
May 7, 2003·Circulation·R Preston Mason, Robert F Jacob
Oct 1, 2005·The Journal of Biological Chemistry·Robert F Jacob, R Preston Mason
Feb 9, 2006·The Journal of Biological Chemistry·R Preston MasonRobert F Jacob
Jun 15, 2006·Nutrition Reviews·Ricardo Uauy, Alan D Dangour
Mar 22, 2007·The Journal of Nutrition·Sheila M Innis
Apr 3, 2007·Lancet·Mitsuhiro YokoyamaUNKNOWN Japan EPA lipid intervention study (JELIS) Investigators
Mar 22, 2008·Journal of the American College of Cardiology·Mary F WalterUNKNOWN PREVENT Investigators
Mar 17, 2010·The New England Journal of Medicine·Henry N GinsbergRobert P Byington
Nov 17, 2011·The New England Journal of Medicine·William E BodenWilliam Weintraub
Aug 3, 2012·Biophysical Journal·Justin A WilliamsStephen R Wassall
Jan 18, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Harold E BaysParesh N Soni
Jan 28, 2014·Cardiovascular Diabetology·Jean-Charles FruchartUNKNOWN Residual Risk Reduction Initiative (R3i)
Mar 7, 2017·Journal of Atherosclerosis and Thrombosis·Tadayoshi Karasawa, Masafumi Takahashi
Jan 15, 2018·Biochemical and Biophysical Research Communications·Samuel C R Sherratt, R Preston Mason
Jun 25, 2018·Journal of the American College of Cardiology·Om P GandaWilliam E Boden
Aug 28, 2018·The New England Journal of Medicine·UNKNOWN ASCEND Study Collaborative GroupJane Armitage
Nov 13, 2018·The New England Journal of Medicine·Deepak L BhattUNKNOWN REDUCE-IT Investigators

❮ Previous
Next ❯

Citations

Jun 11, 2020·Current Opinion in Lipidology·Om P Ganda
Oct 22, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Chengfei WenShumei Liu
Nov 6, 2020·Circulation·Benjamin E PetersonUNKNOWN REDUCE-IT Investigators
Oct 17, 2020·European Heart Journal Supplements : Journal of the European Society of Cardiology·Timothy D O'ConnellGregory C Shearer
Apr 27, 2021·Postgraduate Medicine·John R NelsonRichard L Nemiroff
Jun 3, 2021·Animals : an Open Access Journal From MDPI·Enrico FioreFilippo Fiore
Aug 18, 2021·Journal of Lipid Research·Samuel C R SherrattR Preston Mason
Sep 1, 2021·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Samuel C R SherrattR Preston Mason

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.